You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transduction, Genetic

Showing 1 - 25 of 7,538
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

ß-thalassemia Trial (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • (no location specified)
Mar 15, 2023

ß-thalassemia Trial in Shanghai (BD211)

Not yet recruiting
  • β-thalassemia
  • BD211
  • Shanghai, China
    Shanghai Ruijin Hospital
Mar 16, 2023

Genetic Analyses of Nonsyndromic and Syndromic Deafness in

Enrolling by invitation
  • Hearing Disorder
    • Lahore, Pakistan
      University of Punjab
    Jan 25, 2023

    Genetic Basis of Primary Immunodeficiencies

    Terminated
    • Immunologic Deficiency Syndrome
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      May 26, 2021

      PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM) Trial in La Jolla, Philadelphia (RP-A601)

      Not yet recruiting
      • PKP2 Arrhythmogenic Cardiomyopathy (PKP2-ACM)
      • RP-A601
      • La Jolla, California
      • +1 more
      May 22, 2023

      Healthy Volunteers of Fanconi Anemia, Myeloproliferative

      Completed
      • Chronic Myeloproliferative Disorders
      • +3 more
      • microarray analysis
      • +8 more
      • Portland, Oregon
        Knight Cancer Institute at Oregon Health and Science University
      Jun 30, 2022

      Severe Combined Immunodeficiency Disease, X-linked Trial in San Francisco, Memphis, Seattle (genetic, drug, device)

      Recruiting
      • Severe Combined Immunodeficiency Disease, X-linked
      • CL20-i4-EF1α-hγc-OPT
      • +2 more
      • San Francisco, California
      • +2 more
      Jan 9, 2023

      Fanconi Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Eltrombopag)

      Recruiting
      • Fanconi Anemia
      • Bethesda, Maryland
        National Institutes of Health Clinical Center
      Jan 28, 2023

      NSCLC, Carcinoma, Small Cell Lung, Carcinoma, Thymic Trial run by the National Cancer Institute (NCI) (AZD6244, MK-2206,

      Active, not recruiting
      • Carcinoma, Non-Small-Cell Lung
      • +2 more
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Sympathetic Transduction in Obesity

      Not yet recruiting
      • Hypertension
      • No intervention
      • (no location specified)
      Oct 18, 2022

      Peripheral Blood Hematopoietic Stem Cells, Mononuclear Cells and

      Recruiting
      • Granuloma
      • +4 more
        • Bethesda, Maryland
          National Institutes of Health Clinical Center
        Jan 25, 2023

        Mature B Cell Tumors Trial in Tianjin (SHR1459)

        Active, not recruiting
        • Mature B Cell Neoplasms
        • Tianjin, Tianjin, China
          Blood disease hospital of Chinese Academy of Medical Sciences
        Nov 10, 2022

        Transfusion Dependent Beta-Thalassemia Trial in Nanning (GMCN-508B (LentiRed))

        Recruiting
        • Transfusion Dependent Beta-Thalassemia
        • GMCN-508B (LentiRed)
        • Nanning, Guangxi, China
          The affiliated hospital of guangxi medical university
        Feb 28, 2023

        Cutaneous T Cell Lymphoma, Peripheral T Cell Lymphoma Trial in Boston (Microdevices, Standard of care therapy, Standard of care

        Recruiting
        • Cutaneous T Cell Lymphoma
        • Peripheral T Cell Lymphoma
        • Microdevices
        • +2 more
        • Boston, Massachusetts
          Dana Farber Cancer Institute
        Jul 16, 2022

        Allogeneic Gamma Delta (?d) CAR T Cells

        Enrolling by invitation
        • Lymphoma, Follicular
        • +5 more
        • ADI-001
        • Stanford, California
        • +4 more
        Jun 7, 2022

        Extended Analysis for Leukemia/Lymphoma Treatment

        Completed
        • Relapsed Hematologic Malignancy
        • ngFDS selected treatment
        • Vienna, Austria
          Medical University Vienna
        Feb 22, 2021

        Fanconi Anemia Trial in Barcelona, Madrid (procedure, biological, other, drug)

        Unknown status
        • Fanconi Anemia
        • IV administration of Genetically Engineered Hematopoietic Stem/Progenitors Cells (HSPCs)
        • +5 more
        • Barcelona, Spain
        • +1 more
        Nov 23, 2020

        Patients Who Received Gene-Modified Cell Therapy

        Enrolling by invitation
        • Long-term Follow-up
        • Gene-Modified Cell Therapy
        • Philadelphia, Pennsylvania
          Abramson Cancer Center Clinical Research Unit, University of Pen
        Jul 21, 2022

        Vasoconstriction, Vasodilation Trial in Edmonton (Phenylephrine Hydrochloride, Isoproterenol Hydrochloride, Norepinephrine

        Not yet recruiting
        • Vasoconstriction
        • Vasodilation
        • Phenylephrine Hydrochloride
        • +4 more
        • Edmonton, Alberta, Canada
          University of Alberta
        Aug 21, 2023

        Rational Treatment Trials of Blood Cancer

        Completed
        • Hematologic Diseases
        • Treatment
        • ex-vivo drug response assay
        • Heidelberg, Germany
          University Hospital Heidelberg
        Nov 30, 2021

        Gene Mutation-Related Cancer, Genetic Predisposition Trial (Genetic Information Assistant, Telegenetics with UVA genetic

        Not yet recruiting
        • Gene Mutation-Related Cancer
        • Genetic Predisposition
        • Genetic Information Assistant
        • Telegenetics with UVA genetic counselor
        • (no location specified)
        Oct 17, 2023

        Hematologic Diseases Trial in Kunming (BD211 Drug Product)

        Enrolling by invitation
        • Hematologic Diseases
        • BD211 Drug Product
        • Kunming, Yunnan, China
          920th Hospital of Joint Logistics Support Force of People's Libe
        Aug 14, 2021

        MDD Trial in Shibin Al Kawm (Sildenafil Citrate, Placebo oral tablet)

        Recruiting
        • Major Depressive Disorder
        • Sildenafil Citrate
        • Placebo oral tablet
        • Shibīn Al Kawm, Egypt
          Faculty of Medicine
        Jan 16, 2023

        Malignant Pleural Disease, Mesothelioma, Metastases Trial in United States (iCasp9M28z T cell infusions, cyclophosphamide,

        Active, not recruiting
        • Malignant Pleural Disease
        • +4 more
        • iCasp9M28z T cell infusions
        • +2 more
        • Basking Ridge, New Jersey
        • +5 more
        Nov 14, 2022

        Tumors Trial (ABN401)

        Not yet recruiting
        • Neoplasms
        • (no location specified)
        May 21, 2023